ARID1A/BAF250a as a prognostic marker for gastric carcinoma: A study of 2 cohorts

Human Pathology

Volumn 45, Issue 6, 2014, Pages 1258-1268

  Wiegand, Kimberly C ^a   Sy, Keiyan ^b   Kalloger, Steve E ^a,c   Li Chang, Hector ^a   Woods, Ryan ^d   Kumar, Aalok ^d   Streutker, Catherine J ^e   Hafezi Bakhtiari, Sara ^b   Zhou, Chen ^d   Lim, Howard J ^d   Huntsman, David G ^a,c,d   Clarke, Blaise ^b   Schaeffer, David F ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

ARID1A; BAF250a; Gastric cancer; Microsatellite instability; SWI SNF

Indexed keywords

BAF250A PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MISMATCH REPAIR PROTEIN; PROTEIN; PROTEIN P53; RETINOBLASTOMA BINDING PROTEIN 2; UNCLASSIFIED DRUG;

AGE; ARID1A GENE; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENDER; GENE; GENE AMPLIFICATION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; OVERALL SURVIVAL; PROTEIN DEPLETION; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; TISSUE MICROARRAY;

ARID1A; BAF250A; GASTRIC CANCER; MICROSATELLITE INSTABILITY; SWI/SNF;

ADENOCARCINOMA; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901399943     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.02.006     Document Type: Article

References (19)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. J.N. Wu, and C.W. Roberts ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov. 3 2013 35 43
3. K.C. Wiegand, A.F. Lee, and O.M. Al-Agha et al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas J Pathol 224 2011 328 333
4. S. Jones, M. Li, and D.W. Parsons et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types Hum Mutat 33 2012 100 103
5. K. Wang, J. Kan, and S.T. Yuen et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat Genet 43 2011 1219 1223
6. D.D. Wang, Y.B. Chen, and K. Pan et al. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer PLoS One 7 2012 e40364
7. H. Abe, D. Maeda, and R. Hino et al. ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability Virchows Arch 461 2012 367 377
8. Z.J. Zang, I. Cutcutache, and S.L. Poon et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes Nat Genet 44 2012 570 574
9. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti American Joint Committee on Cancer. AJCC cancer staging manual 7th ed 2010 Springer New York
10. A. Alkushi, B.A. Clarke, and M. Akbari et al. Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data Mod Pathol 20 2007 1156 1165
11. K.C. Wiegand, S.P. Shah, and O.M. Al-Agha et al. ARID1A mutations in endometriosis-associated ovarian carcinomas N Engl J Med 363 2010 1532 1543
12. S. Sif, A.J. Saurin, A.N. Imbalzano, and R.E. Kingston Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes Genes Dev 15 2001 603 618
13. W. Wang, Y. Xue, S. Zhou, A. Kuo, B.R. Cairns, and G.R. Crabtree Diversity and specialization of mammalian SWI/SNF complexes Genes Dev 10 1996 2117 2130
14. R.F. Souza, and S.J. Spechler Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach CA Cancer J Clin 55 2005 334 351
15. M.A. Kim, H.S. Lee, H.K. Yang, and W.H. Kim Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach Cancer 103 2005 1439 1446
16. T. Arai, U. Sakurai, and M. Sawabe et al. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach Gastric Cancer 16 2013 505 512
17. H.S. Lee, S.I. Choi, and H.K. Lee et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability Mod Pathol 15 2002 632 640
18. H. Iizasa, A. Nanbo, J. Nishikawa, M. Jinushi, and H. Yoshiyama Epstein-Barr virus (EBV)-associated gastric carcinoma Viruses. 4 2012 3420 3439
19. J.T. Jorgensen, and M. Hersom HER2 as a prognostic marker in gastric cancer - a systematic analysis of data from the literature J Cancer. 3 2012 137 144